Maximize Your Impact At Rexpo 2025
Rexpo 2025, taking place on September 24 at the PRBB Barcelona Biomedical Research Park in Barcelona, stands out as a critical networking and deal-making forum in the European life sciences sector. The event brings together biotechnology leaders, pharmaceutical executives, medical technology firms, and research institutions—all focused on innovation, partnerships, and investment. Business development teams attend not to observe, but to secure collaborations, initiate licensing discussions, and explore market expansion opportunities across Europe and beyond.
The attendee base is heavily composed of C-level decision-makers, heads of R&D, venture partners, and operational leaders. These stakeholders are either driving their organization’s scientific agenda or allocating resources toward partnerships and purchasing. With Vendelux’s enriched attendee list, teams gain insight into who will be in the room—giving your organization a head start on identifying key accounts, aligning outreach with attendee priorities, and putting relationship-building efforts into motion well before the event day.
How Sales, Marketing and Revops Teams Can Use This Attendee List
Rexpo 2025 attracts executives who oversee research pipelines, evaluate technology platforms, and fund development programs. Sales and marketing teams can use the enriched conference attendee list to filter attendees based on role, company profile, and research focus. For example, business development reps can segment biotech firms seeking commercial partnerships, while technology providers can target pharma companies investing in lab innovation or AI solutions.
Messaging should reflect the scientific or investment goals of each attendee’s organization. Custom outreach that speaks to a specific therapeutic pipeline, regulatory milestone, or business model has a much higher conversion rate. Use verified contact information to book one-on-one meetings with budget authorities ahead of time, increasing the likelihood of meaningful engagement onsite.
The attendee data also helps post-event follow-up stay aligned with the conversations that actually took place—turning brief exchanges into qualified leads and potential deals. The combination of pre-qualified outreach and contextual follow-up dramatically improves how to get more meetings and outcomes from conference attendees.
Timing Is Everything
Rexpo 2025 takes place on September 24, 2025. With just four months remaining until the event, the window for early outreach is now. Companies making partnership and investment decisions are already filling calendars and confirming meetings.
Using Vendelux to engage with the enriched Rexpo 2025 attendee list right now allows your team to identify which stakeholders will be present, prioritize by strategic fit, and begin relationship-building before the competition. Timely outreach means your brand is top of mind once teams arrive in Barcelona—and conversations can move beyond introductions to action.
What’s Included In The Rexpo 2025 Attendee List?
Vendelux provides early visibility into key executives expected to attend Rexpo 2025 through organizer collaboration and proprietary predictive technology. Users can upload a list of high-value target accounts to identify attendee matches and refine outreach.
The enriched list includes first and last names, job titles, company names, company websites, attendee locations (city, state, and country), LinkedIn profiles, verified email addresses, and phone numbers when available.
Where Is Rexpo 2025?
Rexpo 2025 will be held at PRBB Barcelona Biomedical Research Park in Barcelona, Catalunya, Spain.
When Is Rexpo 2025?
Rexpo 2025 is scheduled for September 24, 2025.
What Type Of Event Is Rexpo 2025?
Rexpo 2025 is a business-focused healthcare conference that facilitates partnerships across biotechnology, pharmaceuticals, diagnostics, and medical devices. It includes structured networking, investor and partner matchmaking, industry keynotes, and innovation showcase panels.
How Many People Attend Rexpo 2025?
Rexpo 2025 is expected to host over 600 attendees from more than 30 countries. The audience includes senior executives, founders, investors, and scientific leaders driving commercial and strategic decisions in life sciences and healthcare innovation.
